期刊文献+

干扰素联合炎琥宁治疗小儿手足口病的临床效果观察 被引量:1

Clinical Observation of Interferon Combined with Yanhuning in Treatment of Hand-foot-mouth Disease in Children
下载PDF
导出
摘要 目的分析干扰素联合炎琥宁治疗小儿手足口病的临床效果。方法随机选取2016年1月至2016年12月于本院接受治疗的60例小儿手足口病患儿,随机分为两组,观察组与对照组各30例。给予观察组患者干扰素联合炎琥宁方案治疗,给予对照组患者利巴韦林方案治疗。观察并比较两组患儿治疗后相关症状恢复时间及治疗后临床疗效。结果观察组各指标及疗效均优于对照组,组间具有明显的统计学差异(P<0.05)。结论在小儿手足口病的治疗中应用干扰素联合炎琥宁治疗具有显著的临床疗效,患儿临床症状恢复速度快,安全性高,值得在临床上广泛推广应用。 Objective To analyze the clinical effect of interferon combined with Yanhuning in treatment of children with hand-footmouth disease. Methods 60 children with hand-foot-mouth disease were randomly selected from January 2016 to December 2016, the patients were randomly divided into two groups, there were 30 cases in the observation group and the control group. The observation group was given interferon combined with Yanhuning treatment, the control group was treated with Ribavirin. The recovery time of related symptoms and clinical efficacy after treatment were observed and compared between the two groups. Results The indexes and curative effect of the observation group were better than those of the control group, the difference was statistically significant(P<0.05). Conclusion The clinical curative effect of interferon and Yanhuning in treatment of children with hand-foot-mouth disease is exact, which also can make the clinical symptoms rapidly restored, has high safety, and is worthy of clinical application.
作者 舒珍
出处 《智慧健康》 2017年第17期67-68,共2页 Smart Healthcare
关键词 干扰素 炎琥宁 小儿手足口病 疗效 Interferon Yanhuning Hand-foot-mouth disease in children Curative effect
  • 相关文献

参考文献8

二级参考文献57

  • 1黄永建.手足口病诊治过程中易出现的问题及对策[J].中国当代儿科杂志,2009,11(3):231-232. 被引量:13
  • 2王文琴.干扰素联合炎琥宁治疗小儿手足口病的临床效果观察[J].求医问药(下半月),2013(8):309-310. 被引量:14
  • 3郭玉喜.干扰素a-2b联合炎琥宁在小儿手足口病的治疗中的效果及安全性[J].健康必读(中旬刊),2013,12(3):296.
  • 4郭红,董丽滨,房丽丽.干扰素联合炎琥宁治疗小儿手足口病的临床效果观察.中国药物经济学,2014,14(01):213-214.
  • 5Bo Y C,Song C,Wang J F, et al. Using an autologistic regression model to identify spatial risk factors and spatial risk patterns of hand, foot and mouth disease (HFMD) in China's Mainland[J]. BMC Public Health, 2014, 14(1) :358-362.
  • 6Chan Y F, AbuBaker S. Recombinant human enterovirus 71 in hand, foot and mouth disease patients [ J]. Emerg Infect Dis ,2004,10 : 1468-1470.
  • 7Wang J R, TuanY C, TsaiH P, etal. Change of major genotype of enterovirus 71 in outbreaks of hand-foot- mouth disease in Taiwan between 1998 and 2000[ J]. J Clin Microbiol,2002,40 : 10-15.
  • 8Ma Edmond, Fung Connie, Yip Steven H L, et al. Estimation of the basic reproduction number of enterovirus 71 and coxsaekievirus A16 in hand, foot, and mouth disease outbreaks [ J]. Ped Infect Dis J, 2011, 30(8) :675-679.
  • 9Jadad A R, Moore R A, Carroll D, et al. Assessing the quality of reports of randomized clinical trials :is blindingnecessary [ J]. Control Clin Trials, 1996, 17 ( 1 ) : 1-12.
  • 10郭红,董丽滨,房丽丽.干扰素联合炎琥宁治疗小儿手足口病的临床效果观察[J].中国药物经济学,2014,13(1):213-214.

共引文献61

同被引文献4

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部